Lukáš Bajer

770 total citations
25 papers, 504 citations indexed

About

Lukáš Bajer is a scholar working on Epidemiology, Genetics and Hepatology. According to data from OpenAlex, Lukáš Bajer has authored 25 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Genetics and 9 papers in Hepatology. Recurrent topics in Lukáš Bajer's work include Inflammatory Bowel Disease (10 papers), Liver Diseases and Immunity (8 papers) and Microscopic Colitis (5 papers). Lukáš Bajer is often cited by papers focused on Inflammatory Bowel Disease (10 papers), Liver Diseases and Immunity (8 papers) and Microscopic Colitis (5 papers). Lukáš Bajer collaborates with scholars based in Czechia, United Kingdom and Japan. Lukáš Bajer's co-authors include Pavel Drastich, Jan Březina, Julius Špičák, Miloslav Kverka, Pavel Wohl, Zuzana Stehlíková, Peter Mačinga, Jiří Dvořák, Martin Kostovčík and Jakub Mrázek and has published in prestigious journals such as Gastroenterology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Lukáš Bajer

22 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lukáš Bajer Czechia 10 260 181 137 130 124 25 504
Andreas Koutsoumpas United Kingdom 11 194 0.7× 199 1.1× 215 1.6× 148 1.1× 72 0.6× 29 563
Lorenzo Zileri Dal Verme Italy 11 286 1.1× 147 0.8× 190 1.4× 144 1.1× 78 0.6× 28 595
Jan Březina Czechia 6 214 0.8× 141 0.8× 100 0.7× 118 0.9× 106 0.9× 12 422
Pavel Wohl Czechia 6 178 0.7× 164 0.9× 114 0.8× 93 0.7× 81 0.7× 19 414
Tytti Jaakkola Finland 6 290 1.1× 131 0.7× 170 1.2× 75 0.6× 104 0.8× 8 454
Peter Mačinga Czechia 8 153 0.6× 129 0.7× 66 0.5× 136 1.0× 49 0.4× 17 374
Tomoki Aomatsu Japan 13 259 1.0× 160 0.9× 253 1.8× 157 1.2× 73 0.6× 29 622
Laura Harrell United States 9 232 0.9× 292 1.6× 179 1.3× 181 1.4× 66 0.5× 25 649
Toshinao Itani Japan 8 142 0.5× 150 0.8× 80 0.6× 105 0.8× 41 0.3× 22 401
Diego Saita Italy 10 302 1.2× 147 0.8× 96 0.7× 85 0.7× 95 0.8× 12 600

Countries citing papers authored by Lukáš Bajer

Since Specialization
Citations

This map shows the geographic impact of Lukáš Bajer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukáš Bajer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukáš Bajer more than expected).

Fields of papers citing papers by Lukáš Bajer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukáš Bajer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukáš Bajer. The network helps show where Lukáš Bajer may publish in the future.

Co-authorship network of co-authors of Lukáš Bajer

This figure shows the co-authorship network connecting the top 25 collaborators of Lukáš Bajer. A scholar is included among the top collaborators of Lukáš Bajer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukáš Bajer. Lukáš Bajer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cahová, Monika, et al.. (2025). Unique clinical, morphological, and molecular characteristics of tumors associated with PSC-IBD. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 486(4). 651–661.
2.
Březina, Jan, et al.. (2025). Serological Markers of Intestinal Barrier Function and Inflammation as Potential Predictors of Recurrent Primary Sclerosing Cholangitis. Clinical and Experimental Gastroenterology. Volume 18. 171–178. 1 indexed citations
3.
Wohl, Pavel, Lukáš Bajer, Jan Březina, et al.. (2024). Limited validity of Mayo endoscopic subscore in ulcerative colitis with concomitant primary sclerosing cholangitis. World Journal of Gastrointestinal Endoscopy. 16(11). 607–616.
4.
Bajer, Lukáš, Marvin Ryou, Christopher C. Thompson, & Pavel Drastich. (2024). Novel upper gastrointestinal bleeding sensor capsule: a first human feasibility and safety trial. Clinical Endoscopy. 57(2). 203–208. 2 indexed citations
5.
Coufal, Štěpán, Miloslav Kverka, Jakub Kreisinger, et al.. (2023). Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD. Journal of Immunology Research. 2023. 1–16. 3 indexed citations
6.
Bajer, Lukáš, Pavel Drastich, Karel Harant, et al.. (2023). A Current State of Proteomics in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Search and Review. International Journal of Molecular Sciences. 24(11). 9386–9386. 13 indexed citations
7.
Rob, Filip, Martin Kolář, Jakub Kreisinger, et al.. (2023). Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy. Frontiers in Cellular and Infection Microbiology. 12. 1064537–1064537. 6 indexed citations
8.
Rob, Filip, Zuzana Stehlíková, Jakub Kreisinger, et al.. (2022). Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study. PLoS ONE. 17(12). e0277576–e0277576. 4 indexed citations
9.
Bajer, Lukáš, Marvin Ryou, Christopher C. Thompson, & Pavel Drastich. (2022). 272: NOVEL UPPER-GI BLEEDING SENSOR CAPSULE (PILLSENSE): A FIRST IN HUMAN FEASIBILITY AND SAFETY TRIAL. Gastroenterology. 162(7). S–61. 1 indexed citations
10.
Drastich, Pavel, Lukáš Bajer, Marvin Ryou, et al.. (2022). DETECTION OF UPPER GASTROINTESTINAL BLEEDING USING A NOVEL BLEEDING SENSOR CAPSULE – A PILOT STUDY. Gastrointestinal Endoscopy. 95(6). AB466–AB466. 1 indexed citations
11.
Bajer, Lukáš, et al.. (2022). Histopathological assessment of the microscopic activity in inflammatory bowel diseases: What are we looking for?. World Journal of Gastroenterology. 28(36). 5300–5312. 12 indexed citations
12.
Mačinga, Peter, Lukáš Bajer, Marco Del Chiaro, et al.. (2021). Pancreatic cancer in patients with autoimmune pancreatitis: A scoping review. Pancreatology. 21(5). 928–937. 16 indexed citations
13.
Roubalová, Radka, Martin Kolář, Zuzana Stehlíková, et al.. (2021). Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy. Cells. 10(11). 3188–3188. 21 indexed citations
14.
15.
Coufal, Štěpán, Lukáš Bajer, Zuzana Jirásková Zákostelská, et al.. (2019). Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response. Cells. 8(7). 719–719. 35 indexed citations
16.
Mačinga, Peter, Lukáš Bajer, Soňa Fraňková, et al.. (2019). Pancreatic cancer in liver transplant recipients. Pancreatology. 19. S58–S58.
17.
Bajer, Lukáš, Antonij Slavčev, Peter Mačinga, et al.. (2018). Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease. World Journal of Gastroenterology. 24(43). 4939–4949. 10 indexed citations
18.
Mačinga, Peter, Lukáš Bajer, Jana Malušková, et al.. (2017). Simultaneous occurrence of autoimmune pancreatitis and pancreatic cancer in patients resected for focal pancreatic mass. World Journal of Gastroenterology. 23(12). 2185–2185. 19 indexed citations
19.
Bajer, Lukáš, Miloslav Kverka, Martin Kostovčík, et al.. (2017). Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis. World Journal of Gastroenterology. 23(25). 4548–4548. 262 indexed citations
20.
Březina, Jan, Lukáš Bajer, Julius Špičák, & Pavel Drastich. (2016). Faecal microbial transplantation in inflammatory bowel disease. 70(1). 51–56. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Koutsoumpas Breakdown of academic impact, for papers by Lorenzo Zileri Dal Verme Breakdown of academic impact, for papers by Jan Březina Breakdown of academic impact, for papers by Pavel Wohl Breakdown of academic impact, for papers by Tytti Jaakkola Breakdown of academic impact, for papers by Peter Mačinga Breakdown of academic impact, for papers by Tomoki Aomatsu Breakdown of academic impact, for papers by Laura Harrell Breakdown of academic impact, for papers by Toshinao Itani Breakdown of academic impact, for papers by Diego Saita
Rankless by CCL
2026